| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,230 | 5,056 | 5,704 | 4,894 | | Cost of Revenue | 68 | 62 | 72 | 55 | | | Gross Profit | 7,162 | 4,993 | 5,632 | 4,839 | | | Operating Expenses | | Research Development | 1,695 | 1,190 | 1,175 | 1,020 | | Selling General and Administrative | 4,050 | 4,085 | 4,171 | 3,759 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,417 | (281) | 286 | 60 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 83 | 92 | 105 | 182 | | Earnings Before Interest And Taxes | 1,500 | (189) | 391 | 242 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,500 | (189) | 391 | 242 | | Income Tax Expense | 25 | 9 | 5 | 104 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,475 | (198) | 386 | 137 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,475 | (198) | 386 | 137 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,475 | ($198) | $386 | $137 |
|
0.51% Nasdaq 
Income Statement
